Anne Klibanski, MD, was honored May 29 in a ceremony at Harvard Medical School (HMS) as the first incumbent of the Laurie Carrol Guthart Professorship in Medicine in the Field of Neuroendocrinology. The chair was established in 2008 by Leo A. Guthart, MBA, DBA, and his family members: Rebecca Guthart, Margaret Guthart Strauss and Edward Strauss. Jeffrey Flier, MD, dean of the Faculty of Medicine at Harvard University, hosted the event, which featured remarks by Guthart and Klibanski, as well as Peter L. Slavin, MD, MGH President; and Dennis Ausiello, MD, chief of the MGH Department of Medicine.
"It gives our family great pleasure to be here today and to establish the Laurie Carrol Guthart Professorship in Medicine in honor of my late wife," said Guthart. "As a family, we thought a chair in Laurie’s name would be a wonderful way to honor her memory and, at the same time, to show our gratitude to a truly wonderful and unusual doctor."
Guthart and his family have a close history with Harvard. Guthart received an undergraduate degree in physics from theuniversity in 1958, and a master’s in business administration in 1960 and a doctorate of business administration in 1966, both from Harvard Business School. His daughters, Rebecca and Margaret, graduated from Harvard in 1985 and 1988 respectively, while his wife, Laurie, was a 1960 graduate of Radcliffe College.
Through his work with the Cold Spring Harbor Laboratory, Guthartbecame interested in the MGHNeuroendocrine Unit research using novel technologies to identify genes involved in pituitary tumors.
"The honor celebrates the distinguished role that Dr. Klibanski has had in creating a rigorous research career with the patient at its center," said Ausiello.
Klibanski, an internationally renowned physician/investigator in the area of pituitary and neuroendocrine disorders, is the chief of the Neuroendocrine Unit in the Department of Medicine, director of the Neuroendocrine and Pituitary Tumor Clinical Center and currently serves as chief of the Endocrine Division. A clinical and translational investigator, Klibanski heads the inpatient and outpatient facilities and core laboratories in the Harvard Catalyst Clinical and Translational Science Center.
"This chair will enable continued leadership of the MGH in research, clinical care and training in neuroendocrinology and pituitary disorders," said Klibanski. "Neuroendocrinology is a multidisciplinary field, and the establishment of this chair recognizes the promise and excitement of this scientific and clinical area."